Literature DB >> 17538033

Significant association between leukoaraiosis and metabolic syndrome in healthy subjects.

K Park1, N Yasuda, S Toyonaga, S M Yamada, H Nakabayashi, M Nakasato, T Nakagomi, E Tsubosaki, K Shimizu.   

Abstract

OBJECTIVE: To investigate the relationship between leukoaraiosis (LA), which has been considered as an intermediate substitute of ischemic brain damages, and metabolic syndrome (MetS), which attracts attention as a risk factor for cerebrovascular diseases, in healthy subjects derived from various age groups.
METHODS: We studied 1,030 healthy persons at ages between 28 and 78 years (mean, 52.7 years) with no history of stroke who visited a health care facility for routine health checkups. MetS was defined using the criteria of the National Cholesterol Education Program Adult Treatment Panel III. LA was assessed using the rating scale of the Atherosclerosis Risk in Communities study on MRI. Logistic regression analysis was performed to examine associations between LA and MetS.
RESULTS: A total of 296 (28.8%) subjects had LA on MRI. MetS was significantly associated with the presence of LA (adjusted OR, 3.33; 95% CI, 2.30, 4.84). The association was constant across grades of LA; the adjusted OR was 3.41 (95% CI, 2.30, 5.06) for minimal LA and 3.07 (95% CI, 1.75, 5.38) for LA combining mild, moderate, and severe grades. As for MetS components, elevated blood pressure (adjusted OR, 2.16; 95% CI, 1.57, 2.99), impaired fasting glucose (adjusted OR, 1.64; 95% CI, 1.13, 2.39), and hypertriglyceridemia (adjusted OR, 1.56; 95% CI, 1.08, 2.28) were independently associated with all grades of LA.
CONCLUSIONS: Metabolic syndrome (MetS) was significantly associated with every grade of leukoaraiosis (LA), including the minimal LA. Impaired fasting glucose and hypertriglyceridemia were associated with LA independently of elevated blood pressure. MetS can play an important role in identifying healthy subjects who have an increased risk of LA.

Entities:  

Mesh:

Year:  2007        PMID: 17538033     DOI: 10.1212/01.wnl.0000266562.54684.bf

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Metabolic syndrome and localization of white matter hyperintensities in the elderly population.

Authors:  Florence Portet; Adam M Brickman; Yaakov Stern; Nikolaos Scarmeas; Jordan Muraskin; Frank A Provenzano; Claudine Berr; Alain Bonafé; Sylvaine Artero; Karen Ritchie; Tasnime N Akbaraly
Journal:  Alzheimers Dement       Date:  2012-06-06       Impact factor: 21.566

2.  Association between Cystatin C and SVD in Chinese population.

Authors:  Huang Guoxiang; Lu Hui; Zhou Yong; Ji Xunming; Chen Zhuo
Journal:  Neurol Sci       Date:  2018-09-19       Impact factor: 3.307

Review 3.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

4.  Increased cerebral oxygen metabolism and ischemic stress in subjects with metabolic syndrome-associated risk factors: preliminary observations.

Authors:  Ken Uchino; Ridwan Lin; Syed F Zaidi; Hiroto Kuwabara; Donald Sashin; Nicholas Bircher; Yue-Fang Chang; Maxim D Hammer; Vivek Reddy; Tudor G Jovin; Nirav Vora; Mouhammad Jumaa; Lori Massaro; Julia Billigen; Fernando Boada; Howard Yonas; Edwin M Nemoto
Journal:  Transl Stroke Res       Date:  2010-09-01       Impact factor: 6.829

Review 5.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

6.  Higher intraocular pressure is associated with leukoaraiosis among middle-aged and elderly Koreans without glaucoma or dementia.

Authors:  B-J Park; J-K Kim; Y-J Lee
Journal:  Eye (Lond)       Date:  2014-03-28       Impact factor: 3.775

7.  Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.

Authors:  Eugene L Scharf; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Michelle M Mielke; David S Knopman; Gregory M Preboske; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Mary Machulda; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri
Journal:  Stroke       Date:  2019-09-12       Impact factor: 7.914

8.  Metabolic syndrome, brain magnetic resonance imaging, and cognition.

Authors:  Margherita Cavalieri; Stefan Ropele; Katja Petrovic; Aga Pluta-Fuerst; Nina Homayoon; Christian Enzinger; Anja Grazer; Petra Katschnig; Petra Schwingenschuh; Andrea Berghold; Reinhold Schmidt
Journal:  Diabetes Care       Date:  2010-09-17       Impact factor: 19.112

Review 9.  Metabolic syndrome and stroke.

Authors:  Amytis Towfighi; Bruce Ovbiagele
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

10.  Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race.

Authors:  Brett Kissela; Christopher J Lindsell; Dawn Kleindorfer; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Matthew L Flaherty; Ellen Air; Joseph Broderick; Joel Tsevat
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.